Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Peripheral Blood Stem Cells

Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation

Bone Marrow Transplantation volume 26, pages 723–728 (2000)Cite this article

Abstract

We performed a case-control analysis of 42 patients with advanced leukemia or MDS comparing peripheral blood stem cell (PBSC) with marrow grafts (BMT) from HLA-matched sibling donors. PBSC were mobilized with G-CSF (7.5 μg/kg/day) and yielded a median of 6.7 × 106 CD34+ cells/kg (range, 1.6–15.0) and 2.7 × 108 CD3+ cells/kg (range, 1.1–7.1) vs marrow grafts with a median of 2.0 × 108 nucleated cells/kg (range, 1.8–2.2). Recovery was significantly faster after PBSCT compared to BMT, with a median of 17 (range, 12–26) vs 26 (range, 16–36) days, respectively, to neutrophils >0.5 × 109/l (P < 0.01), and 22 (range, 12–>60) vs 42 (range, 18–>60) days, for platelet recovery (P < 0.01). transplantation of ⩾7 × 106 CD34+ cells/kg accelerated recovery to >20 × 109 l platelets; median 17 days (range, 12–19) vs 23 days (range, 17–36) for those receiving <7 × 106/kg (P = 0.01). PBSC and marrow recipients had similar risks of grades II–IV or III–IV acute GVHD or extensive chronic GVHD (all P > 0.3). At 1 year after PBSCT and BMT, the risk of relapse was 41% and 32%, respectively (P = 0.47), and the probability of survival was 46% and 48%, respectively (P = 0.70). HLA-matched sibling PBSCT resulted in faster neutrophil and platelet engraftment compared to BMT, with no subsequent differences in acute or chronic GVHD, relapse or survival. A minimum of 7 × 106CD34+ cells/kg in PBSC grafts may be required for very rapid platelet engraftment. Bone Marrow Transplantation (2000) 26, 723–728.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy Lancet 1992 339: 640–644

    Article  CAS  PubMed  Google Scholar 

  2. Bensinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor Blood 1993 81: 3158–3163

    CAS  PubMed  Google Scholar 

  3. Hartmann O, Le Corroller AG, Blaise D et al. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial Ann Intern Med 1997 126: 600–607

    Article  CAS  PubMed  Google Scholar 

  4. Smith TJ, Hillner BE, Schmitz N et al. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin’s and non-Hodgkin’s lymphoma J Clin Oncol 1997 15: 5–10

    Article  CAS  PubMed  Google Scholar 

  5. Korbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts Blood 1995 85: 1659–1665

    CAS  PubMed  Google Scholar 

  6. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation Blood 1996 88: 2794–2800

    CAS  PubMed  Google Scholar 

  7. Rosenfeld C, Collins R, Pineiro L et al. Allogeneic blood cell transplantation without post-transplant colony-stimulating factors in patients with hematopoietic neoplasm: a phase II study J Clin Oncol 1996 14: 1314–1319

    Article  CAS  PubMed  Google Scholar 

  8. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease Blood 1997 90: 4705–4709

    CAS  PubMed  Google Scholar 

  9. Couban S, Dranitsaris G, Andreou P et al. Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective Bone Marrow Transplant 1998 22: 1199–1205

    Article  CAS  PubMed  Google Scholar 

  10. Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 1998 21: 995–1003

    Article  CAS  PubMed  Google Scholar 

  11. Scott MA, Gandhi MK, Jestice HK et al. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study Bone Marrow Transplant 1998 22: 273–276

    Article  CAS  PubMed  Google Scholar 

  12. Solano C, Martinez C, Brunet S et al. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study Bone Marrow Transplant 1998 22: 1129–1135

    Article  CAS  PubMed  Google Scholar 

  13. Vigorito AC, Azevedo WM, Marques JFC et al. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies Bone Marrow Transplant 1998 22: 1145–1151

    Article  CAS  PubMed  Google Scholar 

  14. Russell JA, Larratt L, Brown C et al. Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome Bone Marrow Transplant 1999 24: 1177–1183

    Article  CAS  PubMed  Google Scholar 

  15. Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft Br J Haematol 1994 87: 609–613

    Article  CAS  PubMed  Google Scholar 

  16. Weaver CH, Longin K, Buckner CD, Bensinger W . Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor Bone Marrow Transplant 1994 13: 411–415

    CAS  PubMed  Google Scholar 

  17. Prosper F, Stroncek D, Verfaillie CM . Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granylocyte colony-stimulating factor Blood 1996 88: 2033–2042

    CAS  PubMed  Google Scholar 

  18. Weisdorf DJ, Verfaillie CM, Davies SM et al. Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte–macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF Blood 1995 85: 3452–3456

    CAS  PubMed  Google Scholar 

  19. Kersey J, Weisdorf D, Uckun F et al. Allogeneic and autologous bone marrow transplantation for high risk acute lymphoblastic leukemia Leukemia 1992 6: 191–192

    PubMed  Google Scholar 

  20. Enright H, Daniels K, Arthur DC et al. Related donor marrow transplant for chronic myeloid leukemia: patient characteristics predictive of outcome Bone Marrow Transplant 1996 17: 537–542

    CAS  PubMed  Google Scholar 

  21. Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus conference on acute GVHD grading Bone Marrow Transplant 1995 15: 825–828

    CAS  PubMed  Google Scholar 

  22. Atkinson K, Horowitz MM, Gale RP et al. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry Bone Marrow Transplant 1989 4: 247–254

    CAS  PubMed  Google Scholar 

  23. Kaplan EL, Meier P . Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457–481

    Article  Google Scholar 

  24. Le CT . Applied Survival Analysis. New York: John Wiley & Sons, Inc., 1997

  25. Mielcarek M, Martin PJ, Torok-Storb B . Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells Blood 1997 89: 1629–1634

    CAS  PubMed  Google Scholar 

  26. Pan L, Delmonte J Jr, Jalonen CK, Ferrara JL . Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease Blood 1995 86: 4422–4429

    CAS  PubMed  Google Scholar 

  27. Zeng D, Dejbakhsh-Jones S, Strober S . Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation Blood 1997 90: 453–463

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota, USA

    JD Lickliter, PB McGlave, TE DeFor, JS Miller, NK Ramsay, CM Verfaillie, LJ Burns, JE Wagner, T Eastlund & K Dusenbery

  2. Box 480, University of Minnesota Hospital, 420 Delaware Street SE, Minneapolis, 55455, Minnesota, USA

    DJ Weisdorf

Authors
  1. JD Lickliter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. PB McGlave
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. TE DeFor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. JS Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. NK Ramsay
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. CM Verfaillie
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. LJ Burns
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. JE Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. T Eastlund
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. K Dusenbery
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. DJ Weisdorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lickliter, J., McGlave, P., DeFor, T. et al. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation. Bone Marrow Transplant 26, 723–728 (2000). https://doi.org/10.1038/sj.bmt.1702606

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702606

Keywords

This article is cited by

Search

Advanced search

Quick links